Thermo Fisher Scientific Inc., the world leader in serving science,
today announced it has completed the acquisition of Prionics AG, a
privately held animal health diagnostics company.
Founded in 1997, Prionics
is headquartered in Zurich, Switzerland, and has a major production
facility in Lelystad, the Netherlands. Prionics' product line of more
than 50 diagnostic test kits, accessories and biochemicals expands the
portfolio of animal health testing products under the Life Technologies
"Prionics adds a unique blend of expertise and diagnostic solutions to
nw and existing customers," said Kirk Adams, Ph.D., global animal
health leader. "Improved accessibility to animal testing benefits both
veterinarians and livestock producers."
"Combining Prionics under the Life Technologies' brand is certainly a
win-win, since the products and capabilities are highly complementary,"
said Dr. Markus Moser, CEO of Prionics. "We believe this will have a
strong and worldwide impact on the animal health industry."
Prionics brings a state-of-the-art infrastructure along with a certified
tuberculin manufacturing facility, plus additional enzyme-linked
immunosorbent assays (ELISA) under the Life Technologies brand.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science,
with revenues of $17 billion and 50,000 employees in 50 countries. Our
mission is to enable our customers to make the world healthier, cleaner
and safer. We help our customers accelerate life sciences research,
solve complex analytical challenges, improve patient diagnostics and
increase laboratory productivity. Our four premier brands - Thermo
Scientific, Life Technologies, Fisher Scientific and Unity Lab Services
- offer an unmatched combination of innovative technologies, purchasing
convenience and comprehensive support. For more information, please
[ Back To NFVZone's Homepage ]